Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EBITDA: 2020-2025

Historic EBITDA for Incannex Healthcare (IXHL) over the last 6 years, with Jun 2025 value amounting to -$46.7 million.

  • Incannex Healthcare's EBITDA fell 21.57% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.8 million, marking a year-over-year decrease of 113.48%. This contributed to the annual value of -$46.7 million for FY2025, which is 151.94% down from last year.
  • Incannex Healthcare's EBITDA amounted to -$46.7 million in FY2025, which was down 151.94% from -$18.5 million recorded in FY2024.
  • In the past 5 years, Incannex Healthcare's EBITDA ranged from a high of -$70,197 in FY2022 and a low of -$51.1 million during FY2023.
  • For the 3-year period, Incannex Healthcare's EBITDA averaged around -$38.8 million, with its median value being -$46.7 million (2025).
  • Its EBITDA has fluctuated over the past 5 years, first soared by 99.43% in 2022, then plummeted by 72,698.94% in 2023.
  • Over the past 5 years, Incannex Healthcare's EBITDA (Yearly) stood at -$12.4 million in 2021, then reached -$8.5 million in 2021, then skyrocketed by 99.43% to -$70,197 in 2022, then crashed by 72,698.94% to -$51.1 million in 2023, then spiked by 63.73% to -$18.5 million in 2024, then crashed by 151.94% to -$46.7 million in 2025.